Prevalence of hepatitis B virus infection among pregnant women attending prenatal care at Mae Sai Hospital in the border regions of northern Thailand

Background: Hepatitis B virus (HBV) infection is a major public health problem worldwide and a major cause of liver diseases. Pregnant women with HBV infection are reservoir for the virus to transmit it to their child. Most infants (90%) who are infected with HBV will develop chronic infection and 25% will die prematurely from liver cancer or cirrhosis. Objectives: To assess the prevalence of HBV infection among pregnant women attending prenatal care at Mae Sai Hospital, a border region in Northern Thailand. Materials and methods: This retrospective cross-sectional research study collected data from the hospital records database between January 2019 and September 2023. All pregnant women were tested for serum HBsAg marker by the STANDARD Q HBsAg Test. Statistical analyses were conducted using IBM SPSS version 29.0, with logistic regression used to detect the associations between variables at a significance level of p<0.05. Results: The study population comprised 2962 pregnant women, with 29.98% Thai and 70.02% non-Thai divided into Burmese (48.12%) and other ethnic groups (51.88%). The overall prevalence rate of HBV infection among pregnant women was 4.9% (95%CI=4.1-5.7). The HBV prevalence rates of Thai pregnant women and non-Thai pregnant women were 2.9% (95%CI=1.8-4.2) and 5.7% (95%CI=4.7-6.9), respectively. Two variables (nationality and year of birth) were associated with hepatitis B infection. Non-Thai pregnant women had a 2-fold (95%CI=1.998-3.161, p=0.003) greater chance of HBV infection than Thai pregnant women, while Thai pregnant women born before the implementation of the national vaccination program had a 4.2-fold (95%CI=1.757-10.037, p=0.004) greater chance of HBV infection than those born after the program implementation. Conclusion: This study found a lower prevalence of hepatitis B virus infection in pregnant women compared to previous studies. Only born vaccination was an associated factor with hepatitis B infection. It is essential to raise awareness, promote preventive measures, and implement screening before pregnant planning or receiving HBV vaccine to stop the infection during pregnancy leading to stop transmitting of hepatitis B to their children.

Authors

Publication Details

Journal
Journal of Associated Medical Sciences
Published
2025-05-27
DOI
https://doi.org/10.12982/jams.2025.073
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence of hepatitis B virus infection among pregnant women attending prenatal care at Mae Sai Hospital in the border regions of northern Thailand

Krung Phiwpan, Nisarat Saowaros, Phirada Mukphet, Sunarin Inthra et al.
Journal of Associated Medical Sciences
Hepatitis B Virus Studies
article

Prevalence of hepatitis B virus infection among pregnant women attending prenatal care at Mae Sai Hospital in the border regions of northern Thailand

Krung Phiwpan, Nisarat Saowaros, Phirada Mukphet, Sunarin Inthra, Sittiporn Suwannamit
article en

Abstract

Background: Hepatitis B virus (HBV) infection is a major public health problem worldwide and a major cause of liver diseases. Pregnant women with HBV infection are reservoir for the virus to transmit it to their child. Most infants (90%) who are infected with HBV will develop chronic infection and 25% will die prematurely from liver cancer or cirrhosis. Objectives: To assess the prevalence of HBV infection among pregnant women attending prenatal care at Mae Sai Hospital, a border region in Northern Thailand. Materials and methods: This retrospective cross-sectional research study collected data from the hospital records database between January 2019 and September 2023. All pregnant women were tested for serum HBsAg marker by the STANDARD Q HBsAg Test. Statistical analyses were conducted using IBM SPSS version 29.0, with logistic regression used to detect the associations between variables at a significance level of p<0.05. Results: The study population comprised 2962 pregnant women, with 29.98% Thai and 70.02% non-Thai divided into Burmese (48.12%) and other ethnic groups (51.88%). The overall prevalence rate of HBV infection among pregnant women was 4.9% (95%CI=4.1-5.7). The HBV prevalence rates of Thai pregnant women and non-Thai pregnant women were 2.9% (95%CI=1.8-4.2) and 5.7% (95%CI=4.7-6.9), respectively. Two variables (nationality and year of birth) were associated with hepatitis B infection. Non-Thai pregnant women had a 2-fold (95%CI=1.998-3.161, p=0.003) greater chance of HBV infection than Thai pregnant women, while Thai pregnant women born before the implementation of the national vaccination program had a 4.2-fold (95%CI=1.757-10.037, p=0.004) greater chance of HBV infection than those born after the program implementation. Conclusion: This study found a lower prevalence of hepatitis B virus infection in pregnant women compared to previous studies. Only born vaccination was an associated factor with hepatitis B infection. It is essential to raise awareness, promote preventive measures, and implement screening before pregnant planning or receiving HBV vaccine to stop the infection during pregnancy leading to stop transmitting of hepatitis B to their children.

Journal of Associated Medical SciencesVol. 58(3)
University of Phayao
Openalex Percentile: Top 83%
Hepatitis B Virus Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.